NEXARDE Trademark

Trademark Overview

On Friday, October 27, 2006, a trademark application was filed for NEXARDE with the United States Patent and Trademark Office. The USPTO has given the NEXARDE trademark a serial number of 77031186. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 6, 2010. This trademark is owned by Johnson & Johnson. The NEXARDE trademark is filed in the Pharmaceutical Products category with the following description:

Human ophthalmic pharmaceuticals
nexarde

General Information

Serial Number77031186
Word MarkNEXARDE
Filing DateFriday, October 27, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 6, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 14, 2007

Trademark Statements

Goods and ServicesHuman ophthalmic pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 31, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001

Trademark Events

Event DateEvent Description
Monday, December 6, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 6, 2010ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 27, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, May 26, 2010EXTENSION 5 GRANTED
Thursday, May 6, 2010EXTENSION 5 FILED
Wednesday, May 26, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 6, 2010TEAS EXTENSION RECEIVED
Tuesday, November 10, 2009EXTENSION 4 GRANTED
Friday, November 6, 2009EXTENSION 4 FILED
Friday, November 6, 2009TEAS EXTENSION RECEIVED
Thursday, May 7, 2009EXTENSION 3 GRANTED
Wednesday, May 6, 2009EXTENSION 3 FILED
Wednesday, May 6, 2009TEAS EXTENSION RECEIVED
Friday, November 7, 2008EXTENSION 2 GRANTED
Wednesday, November 5, 2008EXTENSION 2 FILED
Thursday, November 6, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 5, 2008TEAS EXTENSION RECEIVED
Wednesday, May 14, 2008EXTENSION 1 GRANTED
Monday, May 5, 2008EXTENSION 1 FILED
Monday, May 5, 2008TEAS EXTENSION RECEIVED
Tuesday, November 6, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 14, 2007PUBLISHED FOR OPPOSITION
Wednesday, July 25, 2007NOTICE OF PUBLICATION
Wednesday, July 11, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 10, 2007ASSIGNED TO LIE
Wednesday, June 6, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 5, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 4, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 4, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 4, 2006NON-FINAL ACTION MAILED
Friday, December 1, 2006NON-FINAL ACTION WRITTEN
Friday, December 1, 2006ASSIGNED TO EXAMINER
Tuesday, October 31, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

nexarde pharmaceuticals ophthalmic human